CVS Health Co. (NYSE:CVS) Shares Sold by Logan Capital Management Inc.

Logan Capital Management Inc. cut its holdings in CVS Health Co. (NYSE:CVS) by 2.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 18,845 shares of the pharmacy operator’s stock after selling 383 shares during the period. Logan Capital Management Inc.’s holdings in CVS Health were worth $1,185,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in CVS. Old North State Trust LLC purchased a new stake in CVS Health in the 3rd quarter valued at about $200,000. Tidal Investments LLC boosted its position in shares of CVS Health by 52.2% in the third quarter. Tidal Investments LLC now owns 112,010 shares of the pharmacy operator’s stock worth $7,043,000 after acquiring an additional 38,408 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in CVS Health in the third quarter valued at approximately $2,071,000. World Investment Advisors LLC raised its stake in CVS Health by 280.7% during the third quarter. World Investment Advisors LLC now owns 27,543 shares of the pharmacy operator’s stock worth $1,732,000 after purchasing an additional 20,308 shares during the period. Finally, Sanctuary Advisors LLC boosted its holdings in shares of CVS Health by 42.0% in the 3rd quarter. Sanctuary Advisors LLC now owns 192,436 shares of the pharmacy operator’s stock valued at $11,163,000 after purchasing an additional 56,890 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Down 0.4 %

NYSE CVS opened at $49.37 on Friday. The company’s fifty day moving average price is $58.34 and its two-hundred day moving average price is $58.62. The company has a market capitalization of $62.13 billion, a price-to-earnings ratio of 12.53, a price-to-earnings-growth ratio of 0.89 and a beta of 0.54. CVS Health Co. has a 12 month low of $48.01 and a 12 month high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period last year, the firm earned $2.21 earnings per share. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. As a group, research analysts predict that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 5.39%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. TD Cowen increased their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. Evercore ISI increased their target price on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research report on Thursday, October 24th. Finally, StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $70.50.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.